Arnold Kriegstein, M.D., Ph.D., spoke at the “Spotlight on Parkinson’s Disease,” an educational event presented at the CIRM Governing Board meeting on May 7, 2008. Kriegstein reviewed the limitations of previous Parkinson’s clinical trials and discussed the prospects for stem cell-based cell replacement therapies for Parkinson’s disease. Kriegstein is a professor of neurology at the University of California, San Francisco School of Medicine. He is also director of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF.
The CIRM-hosted event was presented at the Luxe Hotel in Los Angeles, California in partnership with the University of California, Los Angeles, the University of California, San Francisco, and the Michael J. Fox Foundation.